Related Experiment Video

Updated: Apr 21, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.2K

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

Min Feng, Yi Bao, Zhimei Li

    The Journal of Clinical Investigation
    |November 11, 2014
    PubMed

    Insights

    RASAL2 promotes triple-negative breast cancer (TNBC) invasion and metastasis by activating RAC1 signaling. This RASAL2/ARHGAP24/RAC1 pathway highlights a new therapeutic target for aggressive TNBC.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Triple-negative breast cancer (TNBC) frequently relapses and metastasizes, with underlying molecular mechanisms poorly understood.
    • RASAL2, a RAS-GTPase-activating protein (RAS-GAP), is implicated in cancer, but its role in TNBC is unclear.
    • MicroRNA-203 targets RASAL2, suggesting a regulatory relationship in cancer progression.

    Purpose of the Study:

    • To investigate the role of RASAL2 in TNBC invasion and metastasis.
    • To elucidate the molecular mechanisms by which RASAL2 contributes to TNBC progression.
    • To determine if RASAL2 expression predicts outcomes in TNBC patients.

    Main Methods:

    • Analysis of RASAL2 expression in TNBC patient tumors.
    • Functional studies using cell lines to assess RASAL2's impact on invasion and metastasis.
    • Investigation of RASAL2's interaction with small GTPases, including RAC1 and ARHGAP24.
    • Correlation of RASAL2 expression with clinical outcomes in TNBC patients.

    Main Results:

    • RASAL2 is overexpressed in a subset of estrogen receptor-negative (ER-negative) breast tumors, including TNBC.
    • RASAL2 acts oncogenically in TNBC, driving mesenchymal invasion and metastasis, contrasting its tumor-suppressive role in other breast cancer subtypes.
    • High RASAL2 expression predicts poor disease outcomes in TNBC patients.
    • RASAL2 promotes RAC1 signaling and mesenchymal invasion by antagonizing the RAC1-GAP protein ARHGAP24, independent of its own RAS-GAP activity.

    Conclusions:

    • RASAL2 plays a context-dependent, oncogenic role in TNBC, promoting invasion and metastasis.
    • The RASAL2/ARHGAP24/RAC1 signaling module is a key driver of TNBC tumorigenesis.
    • RASAL2 is a potential biomarker for poor prognosis and a therapeutic target in TNBC.

    More Related Videos

    Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

    Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

    Published on: March 26, 2014

    24.2K
    Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

    Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

    Published on: June 9, 2023

    2.6K

    Related Concept Videos

    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a...
    7.6K
    Small GTPases - Ras and Rho01:24

    Small GTPases - Ras and Rho

    Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
    Three regulatory proteins control their activity:
    5.8K
    Cell Polarization by Rho Proteins01:21

    Cell Polarization by Rho Proteins

    Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
    4.2K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.2K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    1.8K
    MAPK Signaling Cascades01:07

    MAPK Signaling Cascades

    Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
    9.5K